Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
JAMA Oncology
|
December 16, 2016
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review
Conor E Steuer, Madhusmita Behera, Vinicius Ernani, et al.
The Oncologist
|
January 17, 2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis
Madhusmita Behera, Conor E Steuer, Yuan Liu, et al.
Clinical Lung Cancer
|
June 12, 2017
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis
Hiba Z Ahmed, Yuan Liu, Kelli O'Connell, et al.
Clinical Lung Cancer
|
March 29, 2024
Lung Cancer Survival Trends in the Veterans Health Administration
Drew Moghanaki, James Taylor, Alex K Bryant, et al.
Cancer
|
September 19, 2019
Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy
Sibo Tian, Renjian Jiang, Nicholas A Madden, et al.
The Oncologist
|
July 7, 2023
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast
Chloe S Lalonde, Jeffrey M Switchenko, Madhusmita Behera, et al.
Clinical Lung Cancer
|
July 13, 2019
Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database
Sibo Tian, Xinyan Zhang, Renjian Jiang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 9, 2019
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
Badi El Osta, Madhusmita Behera, Sungjin Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 15, 2013
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer
Suresh S Ramalingam, Taofeek K Owonikoko, Madhusmita Behera, et al.
Iscience
|
November 11, 2024
Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981
Richa Sharma, Shagun Sharma, Pratik Shriwas, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
JAMA Oncology
|
December 16, 2016
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review
Conor E Steuer, Madhusmita Behera, Vinicius Ernani, et al.
The Oncologist
|
January 17, 2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis
Madhusmita Behera, Conor E Steuer, Yuan Liu, et al.
Clinical Lung Cancer
|
June 12, 2017
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis
Hiba Z Ahmed, Yuan Liu, Kelli O'Connell, et al.
Clinical Lung Cancer
|
March 29, 2024
Lung Cancer Survival Trends in the Veterans Health Administration
Drew Moghanaki, James Taylor, Alex K Bryant, et al.
Cancer
|
September 19, 2019
Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy
Sibo Tian, Renjian Jiang, Nicholas A Madden, et al.
The Oncologist
|
July 7, 2023
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast
Chloe S Lalonde, Jeffrey M Switchenko, Madhusmita Behera, et al.
Clinical Lung Cancer
|
July 13, 2019
Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database
Sibo Tian, Xinyan Zhang, Renjian Jiang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 9, 2019
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
Badi El Osta, Madhusmita Behera, Sungjin Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 15, 2013
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer
Suresh S Ramalingam, Taofeek K Owonikoko, Madhusmita Behera, et al.
Iscience
|
November 11, 2024
Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981
Richa Sharma, Shagun Sharma, Pratik Shriwas, et al.
Page
of 9